“Semaglutide Reduced Risks of Major Kidney Outcomes Irrespective of CKD Severity in the FLOW Trial”

Publication Title

American Society of Nephrology (ASN) Kidney Week 2024

Document Type

Abstract

Publication Date

10-1-2024

Keywords

spokane; pmrc; washington

Area of Special Interest

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Nephrology

This document is currently not available here.


Share

COinS